You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 13, 2024

Details for New Drug Application (NDA): 022567


✉ Email this page to a colleague

« Back to Dashboard


NDA 022567 describes VIIBRYD, which is a drug marketed by Abbvie and is included in one NDA. It is available from four suppliers. Additional details are available on the VIIBRYD profile page.

The generic ingredient in VIIBRYD is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.
Summary for 022567
Tradename:VIIBRYD
Applicant:Abbvie
Ingredient:vilazodone hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 022567
Suppliers and Packaging for NDA: 022567
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567 NDA Allergan, Inc. 0456-1110 0456-1110-30 30 TABLET in 1 BOTTLE (0456-1110-30)
VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567 NDA Allergan, Inc. 0456-1120 0456-1120-30 30 TABLET in 1 BOTTLE (0456-1120-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jan 21, 2011TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jan 21, 2011TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Jan 21, 2011TE:ABRLD:Yes

Expired US Patents for NDA 022567

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-001 Jan 21, 2011 ⤷  Sign Up ⤷  Sign Up
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-003 Jan 21, 2011 ⤷  Sign Up ⤷  Sign Up
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-002 Jan 21, 2011 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.